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SUMMARY Co-infection of HBV, HCVand HIV is common
because of shared routes of viral transmissionwith
increasedriskofmorbidityandmortality. Anti-HCVandHIV
antibodies of168 HBV patients were assayed. Co-infection
of HCV in HBV patients was seen in four cases (2.4%).
Simultaneous infection of HIV in HBV patents was seen in
three cases (1.8%).There was no simultaneous co-infection
of HCV, HIVandHBV. It is recommended that all patients are
screened for possible co-infections before initiating
treatment.
Introduction
Hepatitis B virus (HBV) is a DNA virus of the
Hepadnaviridae family. It infects 350 million people world-
wide and serological evidence of past or present infection
by HBV has been shown in approximately one-third of the
population. It causes liver diseases ranging from acute hepa-
titis to chronic hepatitis, cirrhosis and hepatocellular carci-
noma (HCC), with nearly one million deaths annually.1 – 2
The epidemiology of HBV resembles that of HIV in trans-
mission, which generally involves blood transfusion, needles
and intimate personal contact.1 The probability of HBV
transmission is 100 times greater than for HIV.3 It is
suggested that HIV patients should routinely be tested for
HBV and HCV infection before initiating HIV treatment.4
Currently, in our country, there are about two million
people with hepatitis B and 200,000 of these are suffering
from chronic hepatitis.5 – 7 Concurrent infections of HIV,
HCV and HBV are considered to be a major health
problem which, over time, have had a very important effect
on world health because their modes of transmission are
similar. Many people with HIV are infected with HBV or
HCV and, in some cases, with all three simultaneously,
which increases the risk of fulminant hepatitis, cirrhosis
and liver cancer.8 – 9
Therefore, the co-infection of hepatitis B infection with
HCV and HIV is an important factor, which has not yet
been determined in the Golestan Province. In this study,
HCV and HIV infections were evaluated in people with
chronic HBV.
Methods
This descriptive study was conducted in 2009 on 168 patients
with hepatitis B in Gorgan, north-east Iran. Our samples were
selected randomly from patients who were referred by special-
ists to the virology diagnostic laboratory of the Golestan
University of Medical Sciences for determination of HBV
viral load: all of them had shown more than 10,000 viral par-
ticles per millilitre. The particle count was done with realtime
polymerase chain reaction in the ABI 5700 system. Samples
were kept at 2808C. HCV and HIV antibody detection was
performed using the ELISA method. HIV and HCV antibody
kits were made by DIA.PRO (Milan, Italy). The specificity
and sensitivity of the HCV antibody kit were 100% and
97.5%, respectively. Specificity and sensitivity for the HIV
antibody kits were 99.8% and 100%, respectively. Data entry
was done using SPSS software version 16 and statistical analy-
sis by Chi-square and t-test were applied. TheP value of0.05
was significant. This trial was accepted by the ethics committee
of the Golestan University of Medical Sciences.
Results
The mean age of the patients studied was 37.12+ 12.07
years and most of were male (76.3%).
HCV co-infection rate
Four cases (2.4%) showed infection with HCV. None of the
patients had co-infection of HCV and HIV in HBV-infected
cases at the same time. All those infected with HCV were
male. The frequency of HCV infection in patients with
HBV with regard to their sex is shown in Table 1. All four
co-infected patients were aged between 21–40 years. Two
of them were aged between 21–30 years and two were
31–40 years.
HIV co-infection rate
Three (1.8%) of the patients infected with HBV were simul-
taneously infected with HIV: two (1.6% of the men) men and
one (2.6% of the women) woman. Among the positive cases,
one was under 20 years old, one patient was in the 41–50
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years age group and another was in the 51–60 years age
group. The frequency of HIV co-infection in patients with
HBV with regard to their sex is shown in Table 2.
Concurrent HIV and HCV infection rate
There was no concurrent HCV and HIV infection in HBV-
infected patients.
Discussion
The different rate of HCV, HBV and HIV co-infection
depends on the regional surveillance and the identification
of risk factors involved in chronicity and treatment. Results
obtained in this study showed that in the co-infection of
seven cases (4.2%), four (2.4%) had HCV and three (1.8%)
had HIV.
The findings of the co-infections of HCV and HBV in our
report are different from those reported in a former study
from our region which showed 12.3% co-infection.10 This
variation could be due to a different number of tested
people (168 versus 1850) and as a result of the chronic
infected patients and genomic detection of infection in our
study. Our findings are similar to another study in Tehran,
among 3714 patients with positive HBs antigen. However,
there was one patient with co-infection of all three
viruses.11 There was also a similarity with a research paper
from India among 100 renal failure patients with 3%
having co-infection of HBV and HCV.12 In a report from
Italy on 1047 prisoners, 4% of had both HIV and HCV infec-
tion but also showed 18% positivity for HCV/HBV
co-infection.13
In contrast, some studies which showed concurrent infec-
tion in intravenous drug users of 20.2% were higher than
seen in ours.14 Co-infection of HBV and HCV in renal
failure is about 37.1% in India.15
There was no significant statistical relation between HBV
infection and HIV or HCV infection in our study and it
does not seem to be comparable. Therefore, there is a need
for further investigation involving larger samples.
All HCV co-infected patients were men aged between 21
to 40 years, perhaps due to their social and cultural behav-
iour.16 – 18 An influence of HCV on HBV infection promoting
occult hepatitis B (OHBV) infection has been suggested.16,19
However, an association between the absence of chronic
HCV and occult HBV infection has also been reported.20
In contrast to the HCV results, co-infection with HIV was
seen in both male and female HBV patients in different age
groups. A significant correlation between HIV resistance
mutations, active HBV and positive HCV status has been
shown before. Furthermore, co-infection of HBV and HCV
enhances the risk of hepatotoxicity caused by HIV antiretro-
viral treatment regimens.21
It has also been suggested that chronicity and rapid pro-
gression to cirrhosis of HBV in HIV co-infected patients is
more frequent.16,22
Conclusions
It is advisable to screen all patients for possible co-infections
before initiating treatment.
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